2-Phenoxy-3-Trichloromethylquinoxalines Are Antiplasmodial Derivatives with Activity against the Apicoplast of

Plasmodium falciparum apicoplast quinoxaline structure-activity relationships trichloromethyl goup

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
26 Jul 2021
Historique:
received: 02 07 2021
revised: 22 07 2021
accepted: 22 07 2021
entrez: 28 8 2021
pubmed: 29 8 2021
medline: 29 8 2021
Statut: epublish

Résumé

The malaria parasite harbors a relict plastid called the apicoplast. Although not photosynthetic, the apicoplast retains unusual, non-mammalian metabolic pathways that are essential to the parasite, opening up a new perspective for the development of novel antimalarials which display a new mechanism of action. Based on the previous antiplasmodial hit-molecules identified in the 2-trichloromethylquinoxaline series, we report herein a structure-activity relationship (SAR) study at position two of the quinoxaline ring by synthesizing 20 new compounds. The biological evaluation highlighted a hit compound (

Identifiants

pubmed: 34451821
pii: ph14080724
doi: 10.3390/ph14080724
pmc: PMC8400257
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-17-CE11-0017
Organisme : Fondation pour la Recherche Médicale
ID : DCM20181039565

Références

J Med Chem. 2012 Apr 12;55(7):2932-42
pubmed: 22236250
Eur J Med Chem. 2014 Aug 18;83:26-35
pubmed: 24946216
Malar J. 2019 Dec 30;18(1):447
pubmed: 31888654
Molecules. 2012 Jul 05;17(7):8105-17
pubmed: 22766802
Nat Med. 2011 Jan;17(1):33-4; author reply 34-5
pubmed: 21217674
J Agric Food Chem. 2018 Nov 21;66(46):12439-12452
pubmed: 30350975
Mutat Res. 1996 Jun;340(2-3):51-65
pubmed: 8692182
Malar J. 2018 Apr 3;17(1):143
pubmed: 29615050
Cell Rep. 2020 Mar 17;30(11):3778-3792.e9
pubmed: 32187549
Nature. 2010 May 20;465(7296):311-5
pubmed: 20485428
Science. 1976 Aug 20;193(4254):673-5
pubmed: 781840
Lancet Infect Dis. 2021 Aug;21(8):1056-1057
pubmed: 33864802
Chem Rev. 2012 Mar 14;112(3):1269-83
pubmed: 22026508
Molecules. 2020 Aug 27;25(17):
pubmed: 32867402
Antimicrob Agents Chemother. 2010 May;54(5):1872-7
pubmed: 20160056
Antimicrob Agents Chemother. 2007 Apr;51(4):1463-72
pubmed: 17242150
Adv Appl Microbiol. 2013;85:119-44
pubmed: 23942150
Bioorg Med Chem Lett. 2017 Apr 15;27(8):1820-1825
pubmed: 28291694
Emerg Infect Dis. 2015 Oct;21(10):1733-41
pubmed: 26401601
Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):
pubmed: 28289248
Nat Med. 2014 Mar;20(3):307-12
pubmed: 24509527
J Pharmacopuncture. 2016 Mar;19(1):7-15
pubmed: 27280044
Antimicrob Agents Chemother. 2014 May;58(5):2586-97
pubmed: 24550329
Eur J Med Chem. 2011 Sep;46(9):4184-91
pubmed: 21741131
Bull Environ Contam Toxicol. 1977 Feb;17(2):225-32
pubmed: 843640
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Malar J. 2017 Jan 13;16(1):26
pubmed: 28086874
Proc Natl Acad Sci U S A. 1975 Mar;72(3):979-83
pubmed: 165497
PLoS Biol. 2011 Aug;9(8):e1001138
pubmed: 21912516
Int J Parasitol. 2017 Feb;47(2-3):137-144
pubmed: 27773518
Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10949-54
pubmed: 20534454
Antimicrob Agents Chemother. 2004 May;48(5):1803-6
pubmed: 15105138
J Antimicrob Chemother. 2020 Oct 1;75(10):2826-2834
pubmed: 32653910
Antimicrob Agents Chemother. 2017 Dec 21;62(1):
pubmed: 29109165
Eur J Med Chem. 2017 Jan 5;125:68-86
pubmed: 27654395
Sci Rep. 2017 Mar 31;7:45871
pubmed: 28361906
Trends Parasitol. 2019 Dec;35(12):953-963
pubmed: 31699532

Auteurs

Dyhia Amrane (D)

Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, CEDEX 05, 13385 Marseille, France.

Christophe-Sébastien Arnold (CS)

ApicoLipid Team, Institute for Advanced Biosciences, Université Grenoble Alpes, 38700 La Tronche, France.

Sébastien Hutter (S)

Aix Marseille Univ, IHU Méditerranée Infection, UMR VITROME, IRD, SSA, Mycology & Tropical Eucaryotic Pathogens, CEDEX 05, 13005 Marseille, France.

Julen Sanz-Serrano (J)

Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain.

Miguel Collia (M)

Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain.

Amaya Azqueta (A)

Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/Irunlarrea 1, 31008 Pamplona, Spain.
Navarra Institute for Health Research, IdiSNA, Irunlarrea 3, 31008 Pamplona, Spain.

Lucie Paloque (L)

LCC-CNRS, Université de Toulouse, CNRS UPR8241, UPS, 31400 Toulouse, France.
MAAP, New Antimalarial Molecules and Pharmacological Approaches, MAAP, Inserm ERL 1289, 31400 Toulouse, France.
Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31400 Toulouse, France.

Anita Cohen (A)

Aix Marseille Univ, IHU Méditerranée Infection, UMR VITROME, IRD, SSA, Mycology & Tropical Eucaryotic Pathogens, CEDEX 05, 13005 Marseille, France.

Nadia Amanzougaghene (N)

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI, 75013 Paris, France.

Shahin Tajeri (S)

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI, 75013 Paris, France.

Jean-François Franetich (JF)

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI, 75013 Paris, France.

Dominique Mazier (D)

Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI, 75013 Paris, France.

Françoise Benoit-Vical (F)

LCC-CNRS, Université de Toulouse, CNRS UPR8241, UPS, 31400 Toulouse, France.
MAAP, New Antimalarial Molecules and Pharmacological Approaches, MAAP, Inserm ERL 1289, 31400 Toulouse, France.
Institut de Pharmacologie et de Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, 31400 Toulouse, France.

Pierre Verhaeghe (P)

LCC-CNRS, Université de Toulouse, CNRS UPR8241, UPS, 31400 Toulouse, France.
CHU de Toulouse, Service Pharmacie, 330 Avenue de Grande-Bretagne, CEDEX 9, 31059 Toulouse, France.

Nadine Azas (N)

Aix Marseille Univ, IHU Méditerranée Infection, UMR VITROME, IRD, SSA, Mycology & Tropical Eucaryotic Pathogens, CEDEX 05, 13005 Marseille, France.

Patrice Vanelle (P)

Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, CEDEX 05, 13385 Marseille, France.
APHM, Hôpital Conception, Service Central de la Qualité et de l'Information Pharmaceutiques, 13005 Marseille, France.

Cyrille Botté (C)

ApicoLipid Team, Institute for Advanced Biosciences, Université Grenoble Alpes, 38700 La Tronche, France.

Nicolas Primas (N)

Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, CEDEX 05, 13385 Marseille, France.
APHM, Hôpital Conception, Service Central de la Qualité et de l'Information Pharmaceutiques, 13005 Marseille, France.

Classifications MeSH